Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
medical device
4
×
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
startups
boston blog main
boston top stories
deals
dihydroergotamine
fda
glaxosmithkline
investing
nirogacestat
raleigh-durham blog main
raleigh-durham top stories
renaissance capital
satsuma pharmaceuticals
springworks therapeutics
10x genomics
3b pharmaceuticals
480 biomedical
abeona therapeutics
acute migrane
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
alkermes
allan kaspar
altria
amgen
amphivena therapeutics
amryt pharma
andrew komjathy
aron knickerbocker
What
biotech
4
×
ipo
companies
markets
public
satsuma
springworks
way
according
activity
akcea
boost
cases
centers
cigarettes
company
control
days
deaths
debut
developing
disease
dog
drug
electronic
firm
followed
genomics
hasn’t
haul
including
injuries
ipos
late
leading
led
life
line
linked
lung
Language
unset
Current search:
biotech
×
" medical device "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs